Home Your basket
• Tuberculosis of the parot...
   Price 5.50 €
• Seven cases of inverted n...
   Price 10.50 €
• Modern lipostructure: The...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Chondrocalcinosis of the ...
   Price 8.50 €
• Facial nerve monitoring d...
   Price 12.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Long term results of KTP ...
   Price 5.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• What we don’t know about ...
   Price 12.50 €
• Parry-Romberg syndrome as...
   Price 12.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Dermatofibrosarcoma protu...
   Price 10.50 €
• Evolution of facial nerve...
   Price 10.50 €
• Submental flap for auricu...
   Price 8.50 €
• Vestibular neuritis: aeti...
   Price 8.50 €
• MIF in Head and Neck canc...
   Price 10.50 €
• Evaluation of the primary...
   Price 5.50 €
• Aneurysmal bone cyst of t...
   Price 5.50 €
• Laryngeal dystonia and as...
   Price 8.50 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Otomycosis...
   Price 10.50 €
• Papillary thyroid microca...
   Price 8.50 €
• Occupational therapy in t...
   Price 8.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Pyogenic granuloma of the...
   Price 8.50 €
• Are we sectioning the coc...
   Price 10.50 €
• Malignant mixed tumor of ...
   Price 5.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Non-Hodgkin's lymphoma of...
   Price 5.50 €

Total Order 277.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE